Rifampicin reduces advanced glycation end products and activates DAF‐16 to increase lifespan in Caenorhabditis elegans

Publisher: John Wiley & Sons Inc

E-ISSN: 1474-9726|14|3|463-473

ISSN: 1474-9718

Source: Aging Cell, Vol.14, Iss.3, 2015-06, pp. : 463-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content